Anti-VRK1(human) Antibody, mouse monoclonal (5D1)

Product#: FNK-71-600
$330.28
Availability:
Ships in 1-2 Weeks

Anti-VRK1(human) Antibody, mouse monoclonal (5D1)


General information 

Cat. No. :FNK-71-600
Size :100 ug
Antigen Species :Human
Host Species :Mouse
Cross Reactivity :Human
Label  :Unlabeled
Reactivity :Human VRK1 protein. Not tested with other species.
Immunogen :Synthetic peptide corresponding to N-terminus of human VRK1,  MPRVKAAQAGRQSSAKRHL-C
Isotype :IgG1, kappa
Application  
  1. Western blotting (1/200~1/1,000 dilution). Highly sensitive chemiluminescence reagents such as Lumi-Light Plus (Roche), ImmunoStar LD, or ImmunoStar Zeta (Wako, Osaka) are recommended.
  2. Immunoprecipitation (assay dependent)
  3. Immunofluorescence staining (1/100 dilution)
  4. Immunohistochemistry (assay dependent)
  5. ELISA (assay dependent)
Storage :-20 oC
Product :Mouse monoclonal antibody (5D1) produced in serum-free medium and purified by propriety
    chromatography under mild conditions (90~98% pure).
Form :1 mg/ml in PBS with 50% glycerol, filter-sterilized.
Data Link :SwissProt: Q99986 Human, Entrez Gene 7443 Human

Antigen Characterization   

Type 

:Serine/threonine protein kinase

Application 

:Protein studies, cell signaling research, cancer research

Species  

:Human

Recombinant 

:Yes


VRK1 in the Cell

The VRK1 gene encodes serine/threonine kinase VRK1 (Vaccinia-Related Kinase 1; 396 aa, 45.5 kDa) which is involved in Golgi disassembly during the cell cycle following phosphorylation by PLK3 during mitosis, and required to induce Golgi fragmentation. It acts by mediating phosphorylation of a downstream target protein 'Thr-18' of p53/TP53 and may thereby prevent the interaction between p53/TP53 and MDM2. It also phosphorylates casein and histone H3. Phosphorylation of the BANF1 gene product disrupts its ability to bind DNA, reduces its binding to LEM domain-containing proteins and causes its relocalization from the nucleus to the cytoplasm.
  • Cell Cycle Regulation: VRK1 plays a critical role in cell growth and division. It is involved in the regulation of the cell cycle, nuclear condensation, and transcription regulation
   
  • p53 Stabilization: VRK1 promotes the stability and nuclear accumulation of the p53 protein, a crucial tumor suppressor that regulates cell division and DNA repair. VRK1 phosphorylates p53 at Thr18, which reduces p53 ubiquitination and prevents its degradation
 
  • Phosphorylation of Transcription Factors**: VRK1 phosphorylates several transcription factors, including ATF2 and c-JUN, thereby regulating their activity. It also phosphorylates histone and casein proteins
 
  • Nuclear Envelope Assembly: VRK1 is involved in the assembly of the nuclear envelope, which is essential for protecting DNA and regulating the movement of molecules into and out of the nucleus
 
  • Chromatin Organization: VRK1 plays a role in the organization of chromatin, which is necessary for proper packaging of DNA into chromosomes and normal cell division

VRK1 in the Human Body

Defects in VRK1 are the cause of pontocerebellar hypoplasia type 1A (PCH1A); also called pontocerebellar hypoplasia with infantile spinal muscular atrophy or pontocerebellar hypoplasia with anterior horn cell disease. PCH1A is characterized by an abnormally small cerebellum and brainstem, central and peripheral motor dysfunction from birth, gliosis and anterior horn cell degeneration resembling infantile spinal muscular atrophy.
 
 
71-600_fig1Description.png
Fig.1. Western blot detection of VRK1 in the crude extracts of human cells.

Lanes 1, 2, 3; HeLa cell extract (5x104 cells) with antibody dilutions at 1/100, 1/500, 1/1000. 
Lanes 4, 5, 6; U2OS cell extract (5x104 cells) with the antibody dilutions at 1/100, 1/500, 1/1,000. As secondary antibody, Alexa488 conjugated goat anti-mouse IgG was used.
ImmunoStar LD (Wako, Osaka) was used as chemiluminescence reagent and images were taken with BIO-RAD ChemiDocXRS

71-600_fig2Description.png
Fig.2. Inhibition of VRK1 expression in human cells by RNAi. specific to VRK1. 

Lane 1; Luciferase RNAi (control).
Lane2; VRK1-1 RNAi. Lane 3;  VRK1-2 RNAi.. Antibody at 1/500 dilution. Lumi-Light Plus (Roche) was used as chemiluminescence reagent. Extracts from 5x104 cells.

71-600_fig3Descrpition.png
Fig.3. Immunoflorescence staining of VRK1 in HeLa cells.

Left; Interphase cells fixed with paraformaldehyde and stained with the antibody at 1/100 dilution.
Right; Metaphase cells. At metaphase, VRK1 dots were detected solely in nuclei.

71-600_fig4.png
Fig.4 Immunofluorescence staining of VRK1 in Hela cells.

Left; Interphase cells fixed with methanol and stained with the antibody at 1/100 dilution.
Right; Metaphase cells.

71-600_fig5.png
Fig.5. Immunofluorescence staining of VRK1 in U2OS cells.

Left; Interphase cells fixed with paraformaldehyde and stained with the antibody at 1/100 dilution.
Right; Metaphase cells.

71-600_fig6.png
Fig.6. Immunofluorescence staining of VRK1 in U2OS cells.

Left; Interphase cells fixed with methanol and stained with the antibody at 1/100 dilution.
Right; Metaphase cells.

Aliases for VRK1 Gene
  • VRK Serine/Threonine Kinase 1 2 3 5
  • Serine/Threonine-Protein Kinase VRK1 3 4
  • Vaccinia Related Kinase 1 2 3
  • EC 2.7.11.1 4 51
  • Vaccinia Virus B1R-Related Kinase 1 3
  • Vaccinia-Related Kinase 1 4
  • PCH1A 3
  • PCH1 3
  • VRK1 5

Logo_BioAcademia.png

Satisfaction
Quality Rating
Value Rating
Style Rating
X